PLASMABLASTIC LYMPHOMA
Clinical trials for PLASMABLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PLASMABLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for PLASMABLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to lock in remission for rare lymphoma
Disease control Not yet recruitingThis study tests whether the drug elranatamab can help keep plasmablastic lymphoma, a rare and aggressive blood cancer, from returning after initial chemotherapy. About 17 adults with or without HIV who have already responded to first treatment will receive elranatamab injections…
Matched conditions: PLASMABLASTIC LYMPHOMA
Phase: PHASE2, PHASE3 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for HIV patients with aggressive lymphoma: early trial launches
Disease control Not yet recruitingThis early-phase trial will test the safety and feasibility of adding the experimental drug glofitamab to standard chemoimmunotherapy (R-CHOP) in 15 people newly diagnosed with HIV-associated large B-cell lymphoma. Glofitamab is a bispecific antibody that helps the immune system …
Matched conditions: PLASMABLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC